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ABSTRACT  
Coupling a hydrophobic drug onto monoclonal antibodies via Lysine residues is a common route 
to prepare antibody-drug conjugates (ADC), a promising class of biotherapeutics. But a few 
chemical modifications on protein surface often increases aggregation propensity, without clear 
understanding of the aggregation mechanisms at stake (loss of colloidal stability, self-assemblies, 
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denaturation...), and the statistical nature of conjugation introduces polydispersity in the ADC 
population, which raises questions on whether the whole ADC population becomes unstable. To 
characterize the average interactions between ADC, we monitored small angle X-ray scattering 
in solutions of monoclonal IgG1 human antibody drug conjugate, with average degree of 
conjugation of 0, 2, or 3 drug molecules per protein. To characterize stability, we studied kinetics 
of aggregation at room temperature. Intrinsic Fuchs stability ratio of the ADC was estimated 
from the variation over time of scattered light intensity and hydrodynamic radius, in buffers of 
varying pH, and at diverse sucrose (0% or 10%) and NaCl (0 or 100 mM) concentrations. We 
show that stable ADC stock solutions became unstable upon pH shift, well below the pH of 
maximum average attraction between IgGs. Data indicates that aggregation can be ascribed to a 
fraction of ADC population usually representing less than 30 mol% of the sample. In contrast to 
the case of (monodisperse) monoclonal antibodies, our results suggest that a poor correlation 
between stability and average interaction parameters should be expected as a corollary of 
dispersity of ADC conjugation. In practice, the most unstable fraction of the ADC population can 
be removed by filtrations, which affects remarkably the apparent stability of the samples. Finally, 
the lack of correlation between the kinetic stability and variations of the average inter-ADC 
interactions is tentatively attributed to the uneven nature of charge distributions and the presence 
of patches on the drug-modified antibodies. 
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Introduction. 
Aqueous solutions of therapeutic proteins and particularly of antibodies are now competing 
with small molecular drugs in the treatment of cancers, autoimmune diseases, and several other 
human diseases, to such an extent that monoclonal antibodies (mAb) became key players in the 
research for new drugs.1,2 The versatility of molecular design of mAb now fuels growing interest 
for the study of patentable modifications of approved antibodies. In this context, antibody-
conjugated particles3 or antibody-drug conjugates (ADC), prepared by coupling mAbs with small 
drug molecules,4 appear as one of the most promising emerging class of biotherapeutics, as they 
can ensure improved targeting of drugs. ADC may be either randomly modified, or prepared by 
single, site-specific coupling yielding well-defined compounds with typically one or a few drug 
molecule per protein. However, biomedical acceptance of new therapeutic proteins, even when 
they are derived from a formerly approved parented antibody, requires to address stability issues 
and in particular to alleviate aggregation. In the case of non-conjugated monodisperse mAbs, 
these requirements are generally fulfilled by decreasing possible attractive interactions between 
pairs of proteins and between proteins and interfaces, which translates to 1) a proper choice of 
the protein sequence, buffer conditions and excipients,5,6 and 2) limiting contacts with 
hydrophobic interfaces.7,8 But the development of ADC has given rise to specific concerns 
related to conjugation-dependent loss of stability, specifically when ADCs are conjugated to 
highly hydrophobic molecules. Open questions about ADC stability include 1) the role of 
conjugated drugs in ADC-ADC interactions, and in particular in inter-ADC attractions and 2) the 
possible role of the polydispersity introduced by the chemical coupling (e.g. how sensitive are 
ADC interactions to the number and distribution of a few chemical modifications on the surface 
of the protein?). Compared to the parent mAb, a more complex interplay emerges accordingly 
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between heterogeneity of ADC, conformational stability, oligomerization and aggregation 
propensity. In particular, aggregation-prone ADC may correspond to a subfraction of the whole 
population of conjugated antibodies. 
We report here a study of ADC aggregation rate as a function of buffer condition, comparing 
parent mAb (ADC0) with mAb carrying on average ~2 (ADC2) or ~3 (ADC3) drug molecules. 
We aimed to identify whether formation of aggregates correlated with inter-ADC average 
interaction. Aqueous solutions of ADC in buffers of varying pH, in the presence or not of 
sucrose and/or NaCl, were used to modulate either long-range Coulomb interactions, or short-
range hydration-related interactions between proteins. The colloidal stability of ADC solutions 
was monitored by variation over time of the mean scattered light intensity, and measurement of 
hydrodynamic radii by dynamic light scattering (DLS). Kinetics data were fitted to a slow 
aggregation model yielding apparent Fuchs stability ratios (based on Smoluchowski's theory, and 
recently used for characterization of protein aggregation,9 including for antibody 10, 11). Small 
angle X-ray scattering (SAXS) enabled us to estimate the influence of buffer composition on 
inter-ADC interactions, and on the shape of ADC molecules. Herein we demonstrate that 
aggregation involved a pH and excipient-dependent subpopulation of ADCs. Our results also 
point out the irrelevance of average interaction parameters (e.g. 2nd virial coefficient) to predict 
stability conditions of ADC. In contrast, kinetics analysis is better suited to investigate the origin 
of instability. 
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Experimental. 
Aliquoted stock solutions of ADCs. 
Water was deionized with a MilliQ Millipore purification system. NaCl (99.9% electrophoretic 
grade), HCl, NaOH, Histidine were from Sigma-Aldrich. Monoclonal human IgG1 
(characteristic features and sequence detailed in ref. 12), named ADC0 in the following, was 
provided by Sanofi as 11.6 g.L-1 stock solutions in 10% w/v sucrose, 10 mM Histidine buffer 
pH 6.5. Antibody-drug conjugate at two different degrees of conjugation were prepared from 
ADC0 by random coupling a hydrophobic drug on the amine group of Lysines (cf. patent 12, 
reaction in aqueous solution of 3 to 5 molar equivalents of the N-hydroxysuccinimide activated 
ester end of an oligoethylenoxide-containing linker). This procedure yielded mixtures of 
antibody conjugated molecules having diverse degree of modification around the average one, 
and a diversity of the distribution of attachment points on the protein. No polishing of this 
polydispersity was attempted. The reaction mix was filtered (pore size 0.2 µm) to remove 
antibody aggregates that may form during the reaction. Finally, the solution was ultrafiltered and 
ADCs were obtained in 10 mM Histidine-HCl buffer. Sucrose was added to the solution by 
mixing with 10 mM Histidine-HCl Sucrose 40%w/v buffer in order to achieve a solution of ADC 
in a 10 mM Histidine-HCl Sucrose 10%w/v buffer, hereafter referred to as HS buffer. Final 
concentrations were determined by UV absorbance measurements, using extinction coefficients 
of 1.47 L.g-1.cm-1 for ADC0 (at 280 nm), and 0.114 L.g-1.cm-1 for the conjugated drug (at 
322 nm). In solutions of ADC2 and ADC3, the protein concentration was determined by 
subtracting the absorbance at 280 nm due to the conjugated drug, as follows: [ADC] (g.L-1) = 
0.6934 × (OD280 – 0.5656× OD322) where ODλ are absorbances at the wavelength λ, and 
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coefficients were calibrated using standard solutions of known compositions. The degree of 
conjugation, or Drug-Antibody Ratio (DAR) – i.e. average number of Lysine coupled with the 
drug per IgG molecule – was estimated from UV-vis absorbance and using a Mw of 150 kDa  
yielding 2.25 and 3.5 for ADC2 and ADC3 respectively, which compares reasonably with the 
determination of DAR of 2.1 and 3.1 respectively as measured by mass spectroscopy (Sanofi 
personal communication). One large batch of each stock ADC solution (ADC0, ADC2 and 
ADC3) was fractionated into 1 mL aliquots that were kept frozen (-80°C) until used. 
Concentrations of stock solutions were 11.6 g.L-1 (ADC0), 5.9 g.L-1(ADC2), and 5.8 g.L-1 
(ADC3). 
Sample purity was assessed by size exclusion chromatography (HPSEC) using a SEC-Viscotek 
system equipped with Protein P3000 CLM 3026 columns, UV and RI detectors, at elution rate of 
0.5 mL.min-1 (eluent Na2HPO4-KH2PO4 0.45 M pH7, and 0.25 M KCl in acetonitrile:water 20% 
v/v). The main peak of ADC monomers may be flanked by minor peaks of oligomers or 
aggregates (Figure SI1 in Supporting Info) or degradation peptides. The peptide degradation 
products were essentially not detected in fresh solutions (Figure SI1 in Supporting Info), and the 
peak area due to oligomers represented less than 2% of the area of monomers in ADC0 and 
ADC2, or ca. 4% in ADC3. 
Kinetics (buffer composition, dilution procedures in buffer) 
To prepare solutions, a frozen aliquot of ADC (1 mL) was rapidly thawed at room temperature 
and used within the next two days. Storage buffer (10 mM Histidine-HCl pH 6.5, 10% w/v 
sucrose) will be noted as “HSB pH 6.5”; the same buffer without sucrose is noted “HB pH 6.5”. 
To minimize osmotic stresses or large pH heterogeneities upon dilution, the dilute solutions for 
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light scattering or SAXS experiments were prepared by mixing one volume (typically 0.5 mL) of 
ADC diluted in HSB pH 6.5 with the same volume of another buffer at pHi (10 mM Histidine-
HCl, 10% w/v sucrose solution, with pHi adjusted in the window between pH 6.5 and pH 10 
prior to mixing). Similarly, ADC solutions at low sucrose content (and/or with NaCl) were 
prepared by first diluting the stock ADC in “HB pH 6.5”, down to twice the final concentration, 
and then mixing this preparation into the same volume of “HB pHi“ buffer with or without NaCl. 
200 ppm sodium azide was also added in the second buffer as a biocide agent. The pH of the 
final mixtures felt in between 6.5 and pHi, and it was measured with a pHmeter. ADC solutions 
were filtered through a syringe filter (Anotop 10, pore size 20 nm or 100 nm, Whatman) either 
prior to the 1:1 v/v mixing (i.e. filtration of the stable dilute solutions of ADC at pH 6.5), or after 
mixing with the buffer at pHi. 
Light scattering 
The aggregation kinetics of ADC at room temperature were assessed by measuring the increase 
with time of the intensity of the light scattered at a fixed angle of 90°, using a Brookhaven 
instruments System (BI-200SM goniometer, BI-9000AT correlator, equipped with a 30 mW 
laser diode operating at a wavelength of 637 nm). Decalin scattering was used as a standard to 
calibrate the intensity. Initial concentrations of ADC were adjusted (from ~ 1 g.L-1 to 0.005 g.L-1) 
in order to observe a significant increase of scattered intensity within a few hours. At these 
dilution conditions, aggregation was sufficiently slow to be negligible during the first 30s, a time 
that were necessary to mix solutions and fix the cell in the scattering device. The scattering 
intensity recorded in solutions at pH 6.5 prior to pH shift was constant. Subsequently to pH shift, 
dilution, and/or addition of sucrose or NaCl, the ADC solutions were kept at rest at 25°C. 
Changes in the scattering intensity were measured as a function of incubation time. Regularly 
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during incubation, a 2-minute long record of homodyne intensity-intensity correlation function 
was performed and size distribution of scatterers were determined by CONTIN and NNLS 
procedures, to yield apparent Stokes radius, Rh. 
Circular Dichroism 
 CD spectra of ADC were recorded at 20°C in the Jasco J/815 spectrophotometer, using quartz 
cells of 1 mm path length. ADC were diluted from their stock solutions into 10 mM NaH2PO4-
NaOH buffer, 10% sucrose, at pH adjusted at 6.5, 7.3, or 7.7 (measurements in HS buffer were 
not possible because of the high UV absorbance of 10mM Histidine). The specific ellipticity [θ] 
was calculated according to the equation: 𝜃 =  !.!×!"×!!!×!   (Eq. 1) 
where θe is the measured ellipticity in millidegrees, l is the path length (cm), and c is the ADC 
concentration (in g.L-1). MR is the mean residue molar mass (we used MR =113.5 g.mol-1). 
 
SAXS 
Synchrotron radiation X-ray scattering was measured on SWING beamline at the SOLEIL 
synchrotron facility in Saclay, France. The incident beam energy was 12 keV. The modulus q of 
the scattering vector is given by q = 4π sin(θ/2)/λ, where θ is the scattering angle, λ is the X-ray 
wavelength which was 0.1 nm. In most experiments the sample to detector (Aviex CCD) 
distance was set to 1817 mm, covering the q-range from 0.06 nm-1 to 7 nm-1. Measurements were 
performed using a thermostated flow-through device for the injection of samples (30-50 µL 
sample placed in the capillary cell between two air bubbles and flowed continuously during the 
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SAXS data acquisition in order to avoid sample degradation by the X-rays). Experiments were 
temperature-controlled at 25°C. Typically 40 successive frames of 0.5 s each were recorded for 
both samples and ADC-free buffers. Each raw frame was corrected from pixel sensitivity, and 
angularly averaged. The final spectra and experimental errors were obtained by averaging over 
all frames and subtracting the buffer spectrum from the sample spectrum. Intensities were scaled 
to absolute units using the scattering of water. 
 
Computation of distorted mAb structures 
Model distorted mAb structures were generated using the PyMol Molecular Graphics System 
(Schrödinger, LLC). First, the X-ray crystal structure of Fab regions of the ADC used in this 
work was superimposed onto the Fab arms of an arbitrarily chosen template mAb monoclonal 
antibody from RSCB Protein Data Bank (pdb entry 1IGT). The Fc domain of this template 
murine mAb was also replaced with a human Fc (pdb file 3DO3). Structural alignment was 
performed using the align function within PyMol, by minimizing the RMS deviation of carbon α 
and backbone atoms of the template and the model. Second, the angle between the Fab and Fc 
domains were calculated from the dot product between two vectors. Briefly, each vector was 
defined as the long axis though each Fab or Fc region, each defined as the line passing through 
the centers of gravity of the immunoglobulin domain folds at the two ends of the Fab and Fc 
regions (resp. VL-VH, CH3-CL, CH1-CH2, see Figure SI2 in SI). The angle between one Fab 
fragment and the Fc domain was then altered by rotation of the Fab arm in the Fab-Fc plane 
(±10° angle increments), The origin of rotation was defined at the onset of the hinge region 
between the Fab and Fc domains (see Figure SI2 in SI). Covalent bonds between Fc and Fab 
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domains in the hinge region were artificially broken to preserve the native shape of each domain 
all along the rotation pathway, and it was ensured that no superimposition occurred between 
atoms from the Fab and Fc domains (which limited the rotation to ±50° angle).  
 
Electrostatic potential calculations and Lysine substitutions 
Electrostatic calculations were performed on the model mAb described above (obtained after 
structural alignment of our model Fab domains and a human Fc domain onto the template 1IGT 
mAb) with the Adaptive Poisson-Boltzmann Solver (APBS) package (PARSE forcefield, 
dielectric constant of 80 – resp. 2 - for the protein exterior –resp. interior, 10 mM ionic strength, 
probe size of 1.4 Å).13, 14 The propKa software package 15, 16was used to assign the pKa values of 
each residue and thus fix their protonation state at pH 7.8. To model drug conjugation onto 
ADC0, target Lysine residues were chosen somewhat arbitrarily at the boundary between highly-
positive regions and protruding negative poles, or in zwitterionic regions, and the surface 
potential was recalculated after substitution by neutral Leucine residues assuming preservation of 
the native structure. The PyMol Molecular Graphics System (Schrödinger, LLC) was used to 
visualization the isocontour potential (± 1 kBT/e). The isoelectric points of the substituted 
structures were also calculated using the propKa software package. 
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Results. 
1- Destabilization of ADC upon variation of buffer composition. 
 The instability of ADC in various buffers was assessed by recording the scattering 
intensity of ADC solutions prepared at varying pH and a fixed protein concentration. Solutions 
were obtained by diluting a filtered (Anotop 10, 0.1 µm pore size) aliquot of stock ADC 
(~6 g.L-1, in HS buffer pH 6.5) with 5-50 fold larger volume of HS buffer pH 6.5, prior to mixing 
at t = 0 (two-fold dilution) with 10 mM Histidine-HCl buffer of pH > 6.5 and pH < 10 (final 
volume 0.8-1 mL, and final pH measured with a glass electrode, cf. method section). In solutions 
of ADC2 and ADC3, the shift of pH immediately resulted in an increase of light scattering 
intensity, indicating that pH shift triggered aggregation (Figure 1). Species of diameter > 100 nm 
were detected by DLS beyond incubation times of a few minutes  (Figure 1D), and diameters 
could reach micrometer range in the case of ADC3. Dilution in buffer of pH 6.5 did not 
destabilize the ADC, which confirms that it was the change in buffer pH, and not handling 
conditions, that made ADC unstable. In both ADC2 and ADC3 solutions, the kinetics of 
aggregation depended markedly on pH, and the maximum rate of the initial intensity variation 
was reached at pH ~ 7.8. To accurately record intensity variation, it was necessary to optimize 
the dilution factor in order i) to avoid that substantial amount of aggregate had formed during the 
time period required to mix and load the sample in the DLS apparatus (< 20 s), and ii) to measure 
intensity variations over a time window of several minutes. To this aim, solutions of ADC3 were 
diluted to a significantly lower concentration (0.03 g.L-1 in Figure1B) than solutions of ADC2 
(0.10 g.L-1), suggesting a lower stability of the ADC having higher conjugation ratio. Similar 
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measurements conducted with solutions of the non-modified mAb required to use the highest 
experimental concentration (0.6 g.L-1 ADC0 in Figure 1C).  
At long times, the scattered intensity reached a plateau that depended on buffer condition (Figure 
2A), but aggregates continued to grow in size (continuous increase of apparent hydrodynamic 
radius as measured by dynamic light scattering, DLS). The plateau intensity was thus reached 
due to the finite value of the wave-vector transfer, q = 4π/λ sin(θ/2): according to Rayleigh-
Gans-Debye light scattering theory, it is expected that the scattering becomes independent on the 
size of scattering species when this size reaches the same order of magnitude as the laser 
wavelength. In this regime, the total intensity varies in proportion to the concentration of 
scattering species. Here, the diameters of aggregates were above 100 nm, and typically of 300 
nm-1000 nm (Figure 1D). Intensities measured at time > 900 s were thus assumed to be 
proportional to the concentration of aggregates.  Consequently, the observation of a plateau 
intensity together with continuous increase of apparent radius suggests that the quantity of 
proteins contributing to the aggregates reaches a maximum, while protein-clusters continuously 
coalesce and stick to each other. An index of aggregation was defined as the height of the plateau 
intensity, I-I0 (where I0 is the initial scattering intensity), normalized by the contribution of IgG 
monomers to the initial scattering (Imono, Figure 2). At the pH of maximum destabilization (pH ~ 
7.8 for ADC2 and ADC3, pH < 7.5 for ADC0) and at incubation time long enough to alleviate 
further significant variation of scattering intensity (here t > 900 s), this index reached ca. 3.5 
(ADC0), 12 (ADC2), and > 52 (ADC3). The variation of the index of aggregation suggests that 
protein clusters form faster and/or involve higher amount of protein upon increasing the degree 
of conjugation of ADC.  
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Figure 1. Aggregation kinetics of ADCs triggered by pH shift, and characterized by light 
scattering. The pH shift was obtained by dilution of stock solutions at pH 6.5 in Histidine-HCl-
sucrose buffers , "HS buffer", to a final ADC concentration of (A) 0.1 g.L-1 ADC2 (B) 0.03 g.L-1 
ADC3, (C) 0.6 g.L-1 ADC0, (D) examples of size distribution in solutions of ADC2, as 
determined by NNLS fit of correlations functions (shown in SI Figure SI3) recorded at time 20-
30 min after pH shift. Reference intensity scattered by decalin = 6 kcps, temperature 25°C, 
scattering angle 90°. 
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Figure 2. Plateau of scattering intensity reached at long incubation times as a function of pH in 
the HS stress buffer. (A) Variation of intensity scattered by a solution of ADC2 (same condition 
as in Figure 1). (B) pH-dependence of the normalized intensity reached at t = 500 s, where I0 is 
the intensity measured at time 0, and Imono is the calculated intensity scattered by ADC monomers 
in the absence of aggregation. Lines are guide to the eye. 
 
2- Effect of sample filtration.  
Prior to light scattering measurements, filtration of protein solutions was indispensable to 
remove contributions from dusts and pre-formed aggregates that may be present in stock 
solutions, and to ensure that only monomers contributed to scattering at time zero. For instance, 
in the case of ADC0 (unmodified mAb), the aggregation involved a very minor fraction of the 
whole protein population (cf Figure 2B) that can be formed during freezing/thawing 
manipulations. Possible consequences of filtration, and specifically adsorption on membranes, 
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shall however not be overlooked because of the hydrophobicity of ADC. UV-vis spectra of ADC 
solutions before and after filtration were clearly indicative of a marked loss of material on the 
filters (Figure SI5 in SI). Namely, in the first drop (50 µL) leaving the filter, the protein 
concentration in filtrate was decreased to less than a tenth of the initial concentration. 
Concentration increased gradually with increasing volume passed through the filter (Figure 3A). 
We estimated by integration over the filtered volumes that a total amount of 60 µg of protein was 
adsorbed before reaching saturation of the filter (Figure 3C). Impact of filtration on the degree of 
conjugation (DAR) was estimated from the ratio of absorbance at 280 nm (protein+drug 
contributions) to absorbance at 322 nm (drug contribution). It is presented in Figure 3B for a set 
of filters, showing that Anotop ones did not lead to a significant variation of DAR (5% is of the 
order of experimental uncertainty), whereas ADC of higher DAR were preferentially retained on 
Millex filters. To avoid bias, we fixed as a standard condition of preparation throughout this 
study: filtration through Anotop membranes that were presaturated by passing 100 µL of the 
protein solution, which ensured that in the absence of aggregates, [ADC] in filtrates was equal 
within uncertainty to [ADC] prior to filtration. 
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Figure 3. Variation of composition of filtrates of ADC solutions at pH 6.5 due to adsorption on 
filters. (A) concentration of ADC3 in filtrate vs filtered volume of a stock solution at 1 g.L-1, (B) 
DAR in filtrate as determined by spectrophotometry (same solution as in (A)), (C) Total mass 
adsorbed on Anotop 0.02 µm filter during repetitive filtration steps through the same filter 
(sample volume of 1 mL was fully filtered at each step, ADC concentrations in samples quoted 
in the Figure). 
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Filtration through presaturated filters was used to estimate the effect of aggregation on the 
DAR of soluble fractions. To this aim, aliquots of the stock solutions of ADC (unfiltered) were 
diluted into Histidine-sucrose buffers at various final pHs, and incubated for 18h. UV-vis spectra 
of solutions were measured immediately after dilution, then at time 18h prior and after filtration 
(Anotop 10, 100 nm pore size). Several successive spectra were collected during the dropwise 
filtration (every ca. 150 µL) until no variation could be detected between two successive 
measurements. The composition of filtrates was thus considered to reflect the fraction of soluble 
(monomer + oligomers) ADC. Representative pH conditions are reported in Table 1. In the 
majority of samples, turbidity was low prior to filtration enabling accurate measurements of 
[ADC] and DAR (Figure 4A), except with ADC3 at pH >7.8 (Figure 4B). Absorbance of filtrates 
at 280 nm was systematically lower than before filtration, suggesting that a fraction of ADC 
formed aggregates with diameters > 100 nm. Absorbance at 280 nm and 322 nm were used to 
determine apparent DAR (see method section). The decrease of DAR in filtrates as compared to 
its initial value before filtration, suggested that ADC with higher DAR aggregated preferentially. 
Small decrease of DAR in the (typically predominant) filterable fraction corresponded to a 
marked increase of DAR in aggregates, well above 2 and typically > 3.5 (i.e. beyond the 
apparent DAR measured in ADC3 stock solution). To estimate the average DAR reached in the 
aggregated fraction (i.e. retained on the filter), we calculated in Table 1 the ratio ([drug]unfiltered - 
[drug]filtered) / ([ADC]unfiltered - [ADC]filtered) where [drug] and [ADC] are molar concentrations. 
These measurements confirmed the poorer stability of antibody-drug conjugates having the 
highest DAR values in the polydisperse population of ADC. 
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Figure 4. UV-vis. absorption spectra of solutions of ADC incubated for 18h in HS buffer prior 
or after filtration on Anotop 10 (100 nm pore size).(A) pH 7.3 and 0.25g.L-1 ADC2, or 0.3 g.L-1 
ADC3 ; (B) pH 7.8 and 0.5 g.L-1 ADC3; "incubated" stands for the unfiltered sample at time 18h 
after mixing in the stress buffer. 
Table 1. DAR variation and % filter-removed aggregates in solutions of ADC as determined 
by UV-vis spectrophotometry at time 18h after pH shift (incubation at room temperature, 
unfiltered solution or filtrates from protein-saturated Anotop 10, see text). 
 ADC2 (0.25 g.L-1) ADC3 (0.5 or 0.3 g.L-1) 
pH 6.8 7.2 7.8 8.2 6.8 7.3 7.8 8.2 
%filtered out a 6 % 3.0% 8% 2.5% 7% 13% 40% 32% 
DAR unfiltered 2.35 2.25 2.30 2.15 3.40 3.55 nd c nd c 
DAR in filtrate 2.15 2.33 2.17 2.0 3.20 3.20 2.90 2.85 
DAR aggregates b ~5.3±0.7 nd 3.8±0.4 nd 4.4±0.5 5.5±0.2 4.6±0.1 5.2±0.1 
a. % aggregates retained in filter = 100×([ADC]filtr-[ADC]0)/[ADC]0, where [ADC]0 is the 
concentration prior to filtration and [ADC]filt in the filtrate. 
b. see text for the definition. Uncertainty was estimated using an experimental error of ±0.5 
mDO for the absorbances, which introduces uncertainties of ~0.05-0.07 in the DAR. "nd" 
indicates that DAR in aggregates could not be reliably estimated due to low % aggregates. 
c not measurable, due to high turbidity (see Figure 4B)  
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 Finally, to assess the role of nascent clusters in ADC instability, we considered the effect of a 
filtration performed just after the pH shift. In this alternative protocol, aggregates that were 
rapidly formed upon dilution in the running buffer were removed at time < 60 s, i.e. after the 
application of the pH stress conditions. Data clearly point to an important impact of filtration on 
aggregation kinetics. In contrast to the slow increase of scattered intensity by mixtures that were 
filtered prior to pH shift (see section above), filtration within 60 s after mixing the stock ADC 
into the Histidine-HCl stress buffer led to fully stable solutions. Here, scattered intensity and 
measured average diameters were constant for days, irrespective of pH (ADC0 and ADC2 in 
Figure SI4 in SI). Hydrodynamic diameters were compatible with the preservation of monomers 
of the protein in these samples. This lack of aggregation in post-stress filtered solutions indicates 
that removal of aggregates formed at short time cancels further aggregation. The residual fraction 
of soluble ADC in filtrate is thus stable. Depending on pH, it may represent a 70% - 90% of the 
whole initial population (see below % aggregates in Table 2)  
 
3-  Kinetics stability in different buffer conditions. 
In order to access to a quantitative index of stability as a function of buffer conditions, the 
kinetics data were fitted to the model of slow colloid aggregation developed by Smoluchowski 
and recently used to analyze "cold-set" protein aggregation 9,10,11). At the onset of irreversible 
aggregation of colloids, this theory predicts that the average molar mass varies in proportion to 
time and initial particle concentration. This variation is reflected in the linear increase of 
scattered intensity, given in Equation 2, as long as the form factor of aggregates does not 
modulate the signal. Equation 2 shall thus be valid at short time, until aggregates are larger than 
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50-100 nm (and as long as deviation from linearity is negligible, which interestingly, goes much 
beyond the formation of protein dimers). 
𝐼 𝑡 = 𝐼(0) 1+ ! !"#!! 𝑡   Eq. 2 
where W is the Fuchs stability ratio, t is the incubation time, [ADC] the concentration of 
protein participating to aggregation, k a constant taken here to be equal to 8kBT/3η, with η the 
buffer viscosity, kB the Boltzmann constant and T the temperature. The validity of equation 2 was 
experimentally assessed by measurements at increasing ADC concentrations in similar 
conditions as described in section 1, and Figures 1 and 2. Figure 5 (and Figure SI6 in SI) zooms 
in the initial increase of scattered light by solutions of ADC initially kept at pH 6.5 (Anotop-
filtered) and  rapidly mixed at time zero with an Histidine-sucrose buffer at a higher pH (1:1 
volume ratio). In the range of concentrations shown, the initial slope of variation of intensity vs 
time increased from almost zero (a slope < 0.01 kcps/s was of the order of noise produced by 
dusts or bubbles after mixing) to > 60 kcps in 100 s. The rate of intensity variation appeared to 
increase in proportion to the square of [ADC] (insets in Figure 5 and SI6 in SI) as expected from 
equation 2. Two practical points are however important to consider. First, scattering suffers from 
a high sensitivity to small amount of large particles, dust or microbubbles, that may affect the 
quality of data. They appeared as abrupt spikes of intensity with short durations (1s-3s). Obvious 
spikes were removed from raw data prior to fitting. Second, the scattering at short times can be 
matched to equation 2 only if theoretical expectation of the absence of aggregates at time zero is 
fulfilled, which implies that the initial scattered intensity must be equal to scattering from buffer 
+ ADC monomers. For instance, measurements at high [ADC] did enable linear extrapolations, 
but with lack of consistency in term of the value of initial intensity. At "too" high [ADC], a 
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significant amount of aggregation occurred within the mixing time and/or sampling time (1s 
sampling and a few seconds needed to mix and then relax the agitation). When practiced in the 
relevant concentration conditions (as in Figure 1 and 5, ADC2 < 0.3 g/L and ADC3 < 0.03 g/L) 
contributions of monomers of ADC to scattering were low (< 3 kcps) and extrapolated initial 
intensities were close to the intensity scattered by the buffer. In Figure 5, extrapolation of 
measured intensities to time zero did generally not exceed 20% increase compared to scattering 
from the buffer+ADC, which indicates that no, or only limited aggregation, took place before we 
started recording.  
A
 
B 
 
Figure 5. Variation with ADC concentration of the aggregation kinetics triggered by pH shift 
at t = 0, and characterized by light scattering. Experimental conditions were the same as in 
Figure 1.(A) ADC2 at pH 8.0±0.05 and 0.06, 0.125, 0.21 g.L-1 ; (B) ADC3 at pH 8.0±0.05 and 
0.08, 0.01, 0.015, 0.02, 0.025 g.L-1. Lines are fits to linear variations of the intensity vs time, 
with corresponding equation shown in the Figure. Insets plot the fitted slopes (×1000) vs the 
square of [ADC] (×1 ADC2 or ×1000 ADC3). 
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 Apparent effective stability ratio, Weff, was then determined by using in Equation 2 the total 
concentration of ADC (aggregation-prone fraction assumed to be 100%). Although this 
calculation overestimated the amount of ADC truly entering in the aggregation process, it gave 
an average index of the kinetics stability. Not surprisingly, Weff of the different ADC in the same 
buffer followed the order ADC3 < ADC2 < ADC0 (Figure 6). Weff was highly sensitive to pH 
(variation of Weff on more than 5 decades), suggesting an important role of the protein ionization 
state. Weff changed to a lesser extent (variation by a factor of 100) with adding 100 mM NaCl or 
sucrose in buffers at fixed pH (Figure 6B). The increasing stability ratio upon increasing the 
ionic strength near pH of minimum stability (7 < pH < 8), indicates the presence of coulomb 
attractions between unstable ADC. The decrease of the stability ratio in the presence of sucrose 
(an osmolyte favoring protein compactness and folding) suggests that conformational stability 
was not the main origin of aggregation. The conventional trend associated with preferential 
hydration of proteins is that the presence of sucrose facilitates interprotein contacts, which is 
here reflected by faster aggregation.17 
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C
 
Figure 6. Fuchs stability ratio of ADCs determined from kinetic data in Figure 1 and Equation 2. 
(A) Weff in buffer with no NaCl and with sucrose, calculated using the total ADC concentration in 
eq. 2, (B) Weff of ADC3 determined in buffer containing or not sucrose (0 ; 0.3 M), and NaCl (0; 
100 mM) in addition to 10 mM Histidine-HCl (C) W* = Weff  × (fraction of ADC aggregated at 
long time, as estimated from data in Figure 2). 
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Plateaus of intensity varied in reverse order compared to the kinetic stability ratio Weff (ADC3 
>> ADC2 > ADC0), suggesting that lower (average) stability as estimated from Weff was 
associated with larger fraction of unstable ADC. To define a stability ratio that is not averaged 
over the whole population, and is representative of the fraction of unstable ADCs, we calculated 
W* using in Equation 2 the concentration of the unstable fraction, which reads W* = Weff × 
(%aggregation-prone ADC). The weight-fraction of aggregates was determined in a few 
reference conditions, by ultracentrifugation of representative solutions and measurement by 
spectrophotometry of the residual soluble fraction of ADC in supernatants (in concentrated 
samples to reach measurable absorbance values). Aggregates typically represented a minor 
fraction of 15%- 30% of the total protein concentration (Table 2). Data in Table 2 were used to 
calibrate the plateau intensities for ADC2 and ADC3 that were assumed to vary in proportion to 
the % aggregated ADC (see Section 1), and thus to calculate W*. Interestingly, variation of W* 
with pH, NaCl, sucrose, and even difference between ADC2 and ADC3 were diminished 
compared to Weff (Figure 6C) but the overall impacts of pH or DAR variation remained 
qualitatively the same. 
 
Table 2. Weight fraction of insoluble ADC2 measured after 24h incubation in stress buffer at 
diverse pH. 
buffer HB+sucrose HB+sucrose +sucrose+NaCl +sucrose+NaCl HB HB 
pH 7.55 8.3 7.6 8.25 7.6 8.05 
% aggregates 25 20 13 15 15 35 
 Initial concentration 0.55 g.L-1; concentration of soluble ADC was determined in supernatants 
after ultracentrifugation at 200 000×g for 15 min.; buffer composition was 10 mM Histidine-HCl 
("HB"), with 100 mM NaCl (+ NaCl), and/or 0.3 M sucrose (+sucrose). 
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4- SAXS study of average protein-protein interaction and preservation of protein shape. 
Characterization by small angle scattering of IgG1 monomers has been the purpose of several 
reports, showing nicely that inter-mAb interaction, and intra-mAb shape can be analyzed by 
SAXS or SANS over a large concentration range (for discussion on form factor and interaction 
potentials of mAbs see ref.18,19,20,21,22). In particular, the applicability of SAXS/SANS in 
monitoring acid-induced, or heat-induced, antibody aggregation was demonstrated.18,22 To 
analyse  data, the following assumption are required: weak inter-aggregates interaction (S(q) of 
aggregates neglected), and additive contributions from aggregates and non-aggregated species, in 
order to substract the contribution of monomer/oligomers from profiles of aggregate-containing 
samples (using scattering profiles of filtered, aggregate-free, samples).18 Solutions of ADC0 and 
ADC2 prepared at pH 6.5 predominantly contained monomers of ADC (vide supra) so that 
SAXS profiles in these conditions were expected to compare with published profiles of mAbs, 
and to be used as reference for further analysis of aggregate-containing solutions. ADC 
scattering was measured by SAXS as a function of pH, in buffers supplemented or not with 
sucrose (0.3 mol.L-1) and NaCl (100 mM), i.e. in conditions that yielded aggregation. SAXS 
spectra recorded at increasing ADC concentrations are shown in Figure 7. To reliably identify 
the signature of ADC-ADC interactions, we first determined the reference scattering curve 
reached in the absence of interaction, i.e. the form factor P(q) of ADC (represented as the full 
lines in Figures 7). P(q) was calculated by linear extrapolation to the zero-concentration limit of 
the concentration-normalized scattering intensities. To this aim, the curves in Figure 7 were 
obtained by subtracting the buffer scattering intensity to raw intensity data, and dividing the 
result by ADC concentration in g/L. This calculation introduced a significant noise at q > 0.2 Å-1. 
Alternative normalization uses the assumption of a good matching with Porod law at high q, and 
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superimposes the data to the same q-4 decrease at q above a threshold (typically > 0.15 Å-1 , see 
18,21).  
 Form factors of ADC0 can be superimposed in the q region > 0.03 Å-1 with form factor 
calculated similarly for ADC2 at pH 6.5. The absence of variation of P(q), specifically in the 
high q window, indicates that attachment of the drug on mAb did not significantly affect the 
overall shape of the protein (which is sensitive to changes of the hinge angle between Fc and Fab 
regions, see below). 
  
 
Figure 7. SAXS scattering spectra of ADC0 (A) and ADC2 (B) at varying ADC concentration in 
10mM Histidine buffer pH 6.5. In both figures, P(q) is the form factor of ADC0 calculated by 
extrapolation of data in Figure 7A to zero concentration. 
 Using P(q) as a reference curve corresponding to zero average interaction between ADC 
molecules, the plot of concentration-normalized spectra at a fixed ADC concentration (at 
4.35 g.L-1) enabled to rank the buffer conditions as a function of the degree of repulsion (low-q 
drop) or attraction (low-q increase compared to P(q)). To estimate graphically the transition pH 
between attractive and repulsive regimes, we represented Sapp(q), the ratio of the measured 
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scattered intensity to P(q) (shifted by a constant factor adjusted between 0.95 and 1.05 in order to 
account for pipetting errors, and to reach a value of 1 at q > 0.05 Å-1, Figure 8). This apparent 
structure factor deviates from unity at low q due to contributions of correlation in the radial 
density of ADCs, with upturns corresponding to overconcentration at short interADC distances, 
i.e. average attractions between the proteins. In the case of ADC0 and ADC2, flat fluctuating 
values around 1.0 were obtained for q > 0.025 Å-1, suggesting that this normalization fairly 
reports the structure factor. Both samples displayed repulsive patterns at pH 6.5, though with 
different magnitude of the low-q variation of Sapp. Not surprisingly, increasing pH decreased 
repulsion and enhanced attraction, presumably because of the gradual charge neutralization of 
the proteins. In the case of ADC0, i.e. when aggregates were absent or in negligible fraction, it 
was possible to measure by light scattering the corresponding virial coefficient that was found to 
vary from 5.3.10-4 mol.mL.g-2 (pH 6.5) down to -2.1.10-4 mol.mL.g-2 (pH9.0). Results shown in 
SI Figure SI7 confirmed the qualitative picture obtained from SAXS: i) the predominance of 
repulsive interactions between ADC0 at pH<7.8, ii) a balance of attraction-repulsion at pH 
between 7.8 and 8.4 (virial coefficient lower than experimental errors), and inter-ADC0 
attractions at pH 9.0.  With increasing DAR, a clear trend was the shift of the balanced (zero) 
mean interaction to lower pHs. The slight drift of Sapp over the whole q range shown in Figure 8C 
(ADC3) may indicate in addition a contribution of oligomers that was not further analyzed. 
Figure 8D summarizes the results by ranking sample conditions (pH, NaCl) along a scale 
indicative of the global magnitude of the low-q variation of Sapp. In buffer without NaCl, 
conditions cancelling interactions are listed as pH ≈ 8.5 (ADC0), pH ≤ 8.0 (ADC2), and pH > 7.0 
(ADC3). Addition of 100 mM NaCl turns repulsive interaction into attractive ones (pH 6.5) or 
slightly decreases the magnitude of repulsion (at high pH, Figure SI8 in SI).  
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Figure 8. Variation with pH of inter-ADC interactions as indicated by scattering spectra at low 
q. Representation of Sapp(q) = I(q)/P(q) for ADC in 10 mM Histidine-HCl solutions. (A) 
4.35 g.L-1 ADC0, (B) 4.35 g.L-1 ADC2, (C) 5 g.L-1 ADC3; (D) buffer conditions qualitatively 
ranked in the order of increasing mean interprotein interaction, as estimated from the rate of low-
q variation of Sapp in Figures 8A-C, and Figure SI8 in ESI. The horizontal black line indicates the 
boundary of vanishing mean interaction. 
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SAXS from ADC solutions prepared at pH > 6.5 were recorded on samples that were not 
filtered, and thus included contributions from aggregates. The absence of experimentally 
significant differences in the high-q (>0.025Å-1) scattering of ADC2 at pH 6.5 and pH 8 suggests 
that aggregation did not introduce detectable correlations between the molecules. This is a hint 
speaking in favor of i) preservation of ADC native-like shape (at the resolution of SAXS), and ii) 
absence of specific orientation between concomitant proteins in aggregates. To estimate the 
magnitude of deformation on IgG monomers that could be detected by SAXS, we generated 
model structures based on pdb crystal structures subjected to relative rotations of the Fab vs Fc 
domains (see experimental section). The pdb file 1IGT was somewhat arbitrarily chosen among 
available crystal structures as a starting scaffold, essentially because SAXS profile of unmodified 
1IGT was closer to P(q) of ADC0 in the high q range (Fig. SI9 in SI). SAXS scattering curves 
were then calculated for each distorted structure using CRYSOL routine of the ATSAS 
package.23 Calculated SAXS profiles revealed that the more obvious indications of relative 
rotations between the domains could be seen in the q-range between 0.1 and 0.2 Å-1 (Figure 9A). 
The impact of shape distortion has been exploited in advanced structural characterization based 
on generation of ensembles of antibody structures to fit high-q SAXS profiles.22 Our present 
illustration is also consistent with the model proposed by Yearley and coll., who calculated the 
form factor based on a robust Y-shaped antibody-like structure (providing general trends that do 
not depends on a specific crystallographic structure).21 It was demonstrated in this work that 
variation of the angles between the two Fab domains, or between one Fab and the Fc domain, is 
reflected by significant shifts at q<0.08Å-1 , and also clear variations of  the slope around 
inflexion points present in the 0.08-0.2 Å-1window. By comparing the theoretical profiles in 
Figure 9A, we estimated that rotation by 20° or more of one single domain is likely to be 
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detected by SAXS. Figure 9B shows the comparison of experimental SAXS profiles for ADC0, 
ADC2 and ADC3 in this range of q. The similarity of all three profiles zoomed on the relevant q-
range suggests that the relative orientation and position of Fab and Fc domains were similar in 
ADC0, ADC2 and ADC3.  
  
Figure 9. SAXS profiles zoomed in the q range where modifications of the tertiary structure are 
expected to significantly change the profile. (A) Calculated SAXS profiles of model structures 
generated from pdb 1IGT file and distorted by rotation of one Fab region relative to the Fc 
domain (see experimental section and Figure SI2 in ESI), (B) experimental SAXS data recorded 
for ADCs. 
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aggregate, though we noticed that aggregation was slower in phosphate compared to Histidine 
buffers.  abrupt , stress-induced, increase of apparent hydrodynamic radius in Fig SI3, while no 
change is detected at the molecular level (CD spectra). This result differs from what is generally 
reported in mAb solution. For instance, measurements on acidic pH-stressed mAbs, as reported 
by B. Veestergaard,22 show a significant loss of monomers while denatured oligomers and 
HMWS become predominant. In ADC however, the predominant scattered intensity goes with a 
minor fraction, about 20%, of the ADC undergoing aggregation (Table 2). Preservation of 
monomer in the soluble, non-aggregated, population is confirmed by stability of radii <12nm 
after filtration (Fig SI4 in SI). In contrast to mAbs solutions, application of a stress has 
presumably a variable impact on the different molecules of ADC present in the same solution, 
which result in " lack " of denaturation of most ADC molecules. 
  
Figure 10. Circular dichroism spectra of ADC diluted at time zero in 10 mM Na2HPO4-
NaH2PO4, 10% sucrose stress buffers . (A) 0.12 g.L-1 ADC0; (B) 0.188 g.L-1 ADC2. "pH6.5" or 
"pH 7.7" stand for data recorded immediately after dilution (scans duration 3 min.), "1h old" 
indicates spectra recorded one hour after dilution.  
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Discussion.  
Kinetic stability vs mean colloidal interactions 
It is generally proposed that well below temperature conditions required for unfolding, here 
near or below room temperature, the mean interactions between proteins in solution correlate 
with propensity to form aggregates. Average interaction, or virial coefficients, are used as direct 
criteria to predict the stability of mAb (see for instance relationship with phase transition 
studies,24,25 SAXS or SANS measurements,18,21,26 predictions based on colloidal stability 27). 
General models based on Fuchs stability ratio and correlation with inter-protein 
attraction/repulsion have accordingly been reported to apply to mAb cold-set aggregation by 
Morbidelli et al.9,11 Alternative origins of instability essentially involve conformational 
transitions, near conditions of structural destabilization of the native fold (mechanisms based on 
non-native aggregation, such as in amyloid aggregation 28). Conformational instability is  
typically expected to be significant in mAb aggregation above 40°-50°C.29,30,31,32,33 (for a recent 
review on aggregation mechanisms see 34) In the present study, kinetics data lacked the signature 
of conformational transition (no lag time nor nucleation regime, no evidence for autocatalysis), 
which justified the use of the colloidal stability model. 
 Maximum aggregation propensity was reached in the pH range 7 to 8 for ADC2 and ADC3, 
as reflected by the smooth minimum in Weff near pH 7.8. In contrast, mean inter-protein 
interactions reflected by SAXS spectra appeared to vary monotonously from weakly repulsive to 
attractive with increasing pH from 6.5 to 8.5, suggesting that maximum attraction between ADCs 
was reached near or above pH 8.5-9.0. Somewhat surprisingly, the evolution toward attractive 
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interactions by increasing the pH above 8 was accompanied by an increase of Weff, i.e. stronger 
average attractions above pH 8 corresponded to slower aggregation kinetics. Other apparent 
inconsistency between interaction pattern and kinetic stability include the stabilizing effect of 
added NaCl at pHs far from the pH of maximum attractive interaction (i.e. far from the 
isoelectric point), where Coulomb repulsions should limit interprotein collisions. Mean attraction 
between ADC is accordingly NOT predictive of the kinetics of aggregation.  Polydispersity is the 
major difference between ADC and model solutions of mAb. Covalent coupling of mAb with the 
drug molecules yielded here a mixture of proteins having diverse drug:mAb ratios, and a variety 
of possible surface distribution of the conjugation points, including uneven ones that may locally 
form densely modified patterns. As opposed to SAXS (that give access to average interactions 
over the whole population of ADC), kinetics of aggregation is primarily sensitive to the unstable 
(sub)fraction of ADCs. Apparent inconsistencies between variations of the average interaction 
parameters and kinetics of aggregation, together with our measurements of the amount of 
aggregates, usually < 30% of the total protein, reveals the specific contribution to instability of a 
subpopulation of ADCs. The predominant contribution of an unstable fraction is also consistent 
with the high stability reached when samples were filtered a few second after application of the 
pH stresses (removal of the unstable fraction). 
 
Influence of Lysine modification onto surface charge distribution on ADC  
We illustrate in this section the presence of patches of opposite charges on ADC, that was 
inferred from the increase of W* with increasing NaCl at pH ~7-8. Figure 11 shows various mAb 
configurations that favor or not the protrusion of local negatively-charged patches upon 
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heterologous substitution in ADC0 of two positively-charged Lysine residues by a neutral 
Leucine ones (model calculated at pH 7.8, see experimental section). The impact of the 
substitution of two Lysine residues on Coulomb potential was generally weak if the residues 
were embedded in a positively charged region (Figure 11B). In contrast, modification of two 
Lysines could turn a weakly charged region into an obvious anionic, protruding pole (Figure 
11C) with a range of negative potential similar to the highest positive protrusions seen in Fab 
domains. The estimated isolectric point did not shift by more than 0.1 pH units, from 8.89 down 
to 8.79 in all the configurations tested (Figure 11D). These purely qualitative and arbitrary 
considerations confirm that a small number of modifications on Lysine are sufficient to create 
charge configurations on ADC that display both positive and negative regions at pH 7.8, while 
being well below the global isoelectric point. Therefore, we propose that stabilization of ADC in 
the presence of NaCl, a behavior that was observed experimentally at pH ~ 7-8, presumably 
involves the decrease of Coulomb attractions between positively and negatively charged patches, 
i.e. an electrostatic surface potential markedly differing from the charge pattern of ADC0 (N.B.: 
this does not preclude that the charged patches may also be hydrophobic, due to attachment of 
the drug). The hypothesis of the involvement of ionic patches in inter-protein bridging is not 
new. It has been reported in reversible phase transition (coacervation) of native globular 
proteins.35 Recent studies suggest that coulomb attraction can also favor irreversible aggregation 
of monoclonal and polyclonal antibodies.36,37,38 The main difference with previous studies relies 
here on the fact that in the case of ADCs, patches are due to the chemical modification and their 
number and composition are accordingly governed by statistic distribution of the modified 
residues. 
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Figure 11. Electrostatic surface isocontour (+/- 1 kBT/e) of mAb (ADC0) calculated using 
Adaptative Poisson-Boltzman Solver software with 10 mM ionic strength and pH 7.8 as 
parameters. (A) Unmodified ADC0 and identification by circles of Lysine residues located in 
regions of near-neutral or weakly negative mean charge. (B) Illustration of an isopotential of a 
doubly-modified ADC (Lysine replaced by Leucine in loci 1 and 2), i.e. near positive "blue" 
protrusions in Fab domains (similar results were obtained with pairs of modifications at the loci 
1, 2 or 3 shown in Figure 11A); (C) Illustration of an isopotential of a doubly-modified ADC 
where replacement of Lysine by Leucine were made at loci 4 and 5. (D) pI calculated with the 
“propKa software” package.16,15 
 
Conclusions. 
Results from light scattering and SAXS on antibody-drug conjugates established the distinct 
influence of composition parameters of the solution (pH, ionic strength, sucrose) on room-
temperature aggregation rate and interprotein interactions. In particular, determination of ADC 
kinetic stability and of average interADC interactions as a function of pH, and with or without 
NaCl in buffers, suggest that the rate of formation of ADC clusters can be maximal under 
Locus of	Lys-Leu replacement pI th
Unmodified	ADC0 8.89
Locus	1 8.84
Locus	2 8.84
Locus	3 8.84
Locus	1	+	locus	2 8.78
Locus 1	+	locus	4 8.79
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conditions corresponding to weak average repulsions between the proteins. The conjugation of 
monodisperse monoclonal antibody introduces a degree of polydispersity in ADC that is 
proposed to be at the origin of the counterintuitive observation of a minimal stability at pH 
conditions corresponding experimentally to average repulsions, or weak interactions between 
ADC. Involvement of a pH-dependent subset of the whole population of ADC is validated by 
measurement of the fraction of aggregated proteins that typically reached plateaus below 20-
35 mol%, and by the high, days-long stability of the filtrates obtained just after a pH-triggered 
destabilization (containing the majority of the initial ADCs). Overall, this study demonstrates 
that ADC polydispersity (here due to the number and distribution of chemically modified 
Lysines) should not be overlooked, particularly when developing formulation of therapeutic 
antibody-drug conjugates. On more fundamental grounds, protein conjugates having a structural 
diversity due to the variability of discrete, residue-specific, surface modifications provide a new 
experimental model that opens interesting questions in the field of colloid aggregation. 
  
Supporting Information. SEC analysis of ADC, images of distorted IgG, UV-vis. absorption 
spectra before and after filtrations, light scattering data, SAXS spectra are available free of 
charge via the Internet at http://pubs.acs.org. 
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